← Open Payments lookup

JEREMIAS ABUEME: Open Payments

NPI 1891790960 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$553 in 33 payments from 8 companies in 2025. Trend: 2023 $1,022 · 2024 $951 · 2025 $553

Food & beverage: $553
CompanyPaymentsAmount
Amgen Inc.15$184
Boehringer Ingelheim Pharmaceuticals, Inc.5$107
GlaxoSmithKline, LLC.5$99
AstraZeneca Pharmaceuticals LP3$56
Novo Nordisk Inc2$53
Lilly USA, LLC1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: OTEZLA, JARDIANCE, TRELEGY ELLIPTA, Ozempic, REPATHA, MOUNJARO, KRYSTEXXA, BREZTRI.

Industry payments across TX — which companies pay providers there.